At physiological concentrations, angiotensinogen (AGT), des(angiotensin I)angiotensinogen (des[Ang I]-AGT), and reactive center loop cleaved AGT affect endothelial cell (EC) phenotype toward antiangiogenesis. The renin-angiotensin system (RAS) and the kallikrein-kinin system (KKS), regarded as opposing forces in blood pressure control, share instead similarities as modulators of EC biology. Cleavage of kininogen (KNG) by kallikrein leads to formation of des(kinin)-KNG, which, similar to des(Ang I)-AGT, is antiangiogenic. 2 Furthermore, angiotensin-converting enzyme (ACE) generates Ang II and degrades kinins, and both of these effects are considered proangiogenic. By extension, attention should be paid to the consequences that antihypertensive treatment, by interfering with RAS and KKS, might have on reparative or tumoral angiogenesis.
provided by Celerier et al, des(Ang I)-AGT accumulation may have a role in negatively influencing reparative angiogenesis.
The above discrepancies should be reconsidered in accordance with the proposal introduced by Celerier that local environment may influence the final biological response. Furthermore, genetic alterations of system components may alternatively cause angiogenesis or antiangiogenesis to prevail. Therefore, in a therapeutic perspective, the most accurate scrutiny is required in the use of ACEI and AT 1 antagonists under conditions where angiogenesis is necessary or undesired. 
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